Literature DB >> 9098875

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

R N Alyautdin1, V E Petrov, K Langer, A Berthold, D A Kharkevich, J Kreuter.   

Abstract

PURPOSE: The possibility of using polysorbate 80-coated nanoparticles for the delivery of the water insoluble opioid agonist loperamide across the blood-brain barrier was investigated. The analgesic effect after i.v. injection of the preparations was used to indicate drug transport through this barrier.
METHODS: Loperamide was incorporated into PBCA nanoparticles. Drug-containing nanoparticles were coated with polysorbate 80 and injected intravenously into mice. Analgesia was then measured by the tail-flick test.
RESULTS: Intravenous injection of the particulate formulation resulted in a long and significant analgesic effect. A polysorbate 80 loperamide solution induced a much less pronounced and very short analgesia. Uncoated nanoparticles loaded with loperamide were unable to produce analgesia.
CONCLUSIONS: Polysorbate 80-coated PBCA nanoparticles loaded with loperamide enabled the transport of loperamide to the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098875     DOI: 10.1023/a:1012098005098

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow.

Authors:  C J Porter; S M Moghimi; L Illum; S S Davis
Journal:  FEBS Lett       Date:  1992-06-22       Impact factor: 4.124

2.  Differential properties of organ-specific serum opsonins for liver and spleen macrophages.

Authors:  S M Moghimi; H M Patel
Journal:  Biochim Biophys Acta       Date:  1989-09-18

3.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine.

Authors:  C J Niemegeers; F M Lenaerts; P A Janssen
Journal:  Arzneimittelforschung       Date:  1974-10

4.  Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

Authors:  J Kreuter; R N Alyautdin; D A Kharkevich; A A Ivanov
Journal:  Brain Res       Date:  1995-03-13       Impact factor: 3.252

5.  Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.

Authors:  T Blunk; D F Hochstrasser; J C Sanchez; B W Müller; R H Müller
Journal:  Electrophoresis       Date:  1993-12       Impact factor: 3.535

6.  Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.

Authors:  M N Azmin; J F Stuart; K C Calman; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.

Authors:  M N Azmin; J F Stuart; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Loperamide: evidence of interaction with mu and delta opioid receptors.

Authors:  G Giagnoni; L Casiraghi; R Senini; L Revel; D Parolaro; M Sala; E Gori
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

  8 in total
  47 in total

1.  Recent advances in nanotechnology based drug delivery to the brain.

Authors:  Li-Na Lin; Qun Liu; Lei Song; Fang-Fang Liu; Jin-Xiu Sha
Journal:  Cytotechnology       Date:  2010-08-11       Impact factor: 2.058

2.  Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.

Authors:  Robert M Koffie; Christian T Farrar; Laiq-Jan Saidi; Christopher M William; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 3.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 4.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

Review 5.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

Authors:  J Lode; I Fichtner; J Kreuter; A Berndt; J E Diederichs; R Reszka
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 7.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

8.  Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.

Authors:  J C Olivier; L Fenart; R Chauvet; C Pariat; R Cecchelli; W Couet
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

9.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.

Authors:  E Garcia-Garcia; S Gil; K Andrieux; D Desmaële; V Nicolas; F Taran; D Georgin; J P Andreux; F Roux; P Couvreur
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

Review 10.  Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.

Authors:  Gabriel A Silva
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.